Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.50205 | 71 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.43674 | 71 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.43619 | 71 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.12153 | 67 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.4841 | 71 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.77592 | 74 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.53701 | 72 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.39481 | 70 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.37204 | 70 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.39845 | 70 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.29919 | 70 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.37068 | 70 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.43635 | 71 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.42423 | 71 |